Statistics for Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

Total visits

views
Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer 221

Total visits per month

views
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0

File Visits

views
oncotarget-09-5274.pdf 194

Top country views

views
United States 175
Germany 12
Ukraine 4
United Kingdom 3
Bulgaria 1
Canada 1
Switzerland 1
China 1
Greece 1
South Korea 1
Malaysia 1
Poland 1
Russia 1
Sweden 1

Top city views

views
Wilmington 54
Fairfield 28
Cambridge 15
Ann Arbor 12
Houston 12
Kiez 9
Jacksonville 7
Kiev 4
San Francisco 4
White Plains 4
Athens 1
Bergheim 1
Brooklyn 1
Cointrin 1
Columbus 1
Gunzenhausen 1
London 1
Mountain View 1
Philadelphia 1
Plauen 1
Saint Petersburg 1
Scottsdale 1
Seoul 1
Seremban 1
Sofia 1
Stockholm 1
Toronto 1
Washington 1
Zgierz 1